A director at Lvmh Moet Hennessy Louis Vuitton SE bought 33,033 shares at 455.039EUR and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the...
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Data from the positive Phase 2 study evaluating rilzabrutinib for the treatment of IgG4-related disease presented at EULAR 2025Additional orphan designation underscores Sanofi commitment to advancing new medicines in immune-mediated rare diseases Paris, August 14, 2025. The European Medicines Agency has granted orphan designation to rilzabrutinib, a reversible covalent Bruton’s tyrosine kinase (BTK) inhibitor, ...
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4 Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4 Données de l’étude positive de phase 2 évaluant le rilzabrutinib pour le traitement de la maladie liée aux IgG4 présentée à l’EULAR de 2025Cette nouvelle désignation de médicament orphelin souligne l’engagement de Sanofi en faveur du développement de nouveaux médicaments contre les maladies rares à médiation immunitaire Paris, le 14 août 2025. ...
LVMH: Share transactions disclosure Paris, August 12th, 2025 The disclosure of share transactions carried out from August 4th to August 8th, 2025, was sent to the AMF on August 12th, 2025. As required by current law, this document is publically available and can be consulted on the Company’s website () under the section «regulated information». LVMH LVMH Moët Hennessy Louis Vuitton is represented in Wines and Spirits by a portfolio of brands that includes Moët & Chandon, Dom Pérignon, Veuve Clicquot, Krug, Ruinart, Mercier, Château d’Yquem, Domaine du Clos des Lambrays, Château Cheval Bl...
LVMH : Déclaration des transactions sur actions propres Paris, le 12 août 2025 La déclaration des transactions sur actions propres réalisées du 4 au 8 août 2025 a été adressée à l’Autorité des Marchés Financiers le 12 août 2025. Ce document est tenu à la disposition du public dans les conditions prévues par la réglementation en vigueur et peut être consulté dans la rubrique «information réglementée» du site internet de la Société (). LVMH LVMH Moët Hennessy Louis Vuitton est présent dans les Vins & Spiritueux au travers notamment des Maisons Moët & Chandon, Dom Pérignon, Veuve Clicquot, ...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 2 May 2025, in total 7,738,842 shares were repurchased during the week of 4 August 2025 up to and including 8 August 2025. The shares were repurchased at an average price of €19.72 for a total amount of €152,633,577.73. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share capital...
Communiqué de presse : Sanofi finalise l’acquisition de Vigil Neuroscience, Inc. Sanofi finalise l’acquisition de Vigil Neuroscience, Inc. Paris, le 6 août 2025. Sanofi annonce la finalisation de (« Vigil »). Cette acquisition renforce le pipeline de Sanofi en neurologie avec le VG-3927, un nouvel agoniste oral de TREM2, qui sera évalué dans une étude clinique de phase 2 chez des patients atteints de la maladie d’Alzheimer. En outre, l’acquisition du pipeline préclinique de Vigil renforcera la recherche de Sanofi dans diverses maladies neurodégénératives. En juin 2024, Sanofi a réalisé u...
Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. Sanofi completes the acquisition of Vigil Neuroscience, Inc. Paris, August 6, 2025. Sanofi announces the completion of (“Vigil”). This acquisition strengthens Sanofi’s early-stage pipeline in neurology with VG-3927, a novel, oral, small-molecule TREM2 agonist, which will be evaluated in a phase 2 clinical study in patients with Alzheimer’s disease. In addition, the acquisition of Vigil’s preclinical pipeline will further strengthen Sanofi’s research in various neurodegenerative diseases. In June 2024, Sanofi ...
LVMH: Share transactions disclosure Paris, August 5th, 2025 The disclosure of share transactions carried out from July 28th to August 1st, 2025, was sent to the AMF on August 5th, 2025. As required by current law, this document is publically available and can be consulted on the Company’s website () under the section «regulated information». LVMH LVMH Moët Hennessy Louis Vuitton is represented in Wines and Spirits by a portfolio of brands that includes Moët & Chandon, Dom Pérignon, Veuve Clicquot, Krug, Ruinart, Mercier, Château d’Yquem, Domaine du Clos des Lambrays, Château Cheval B...
LVMH : Déclaration des transactions sur actions propres Paris, le 5 août 2025 La déclaration des transactions sur actions propres réalisées du 28 juillet au 1 août 2025 a été adressée à l’Autorité des Marchés Financiers le 5 août 2025. Ce document est tenu à la disposition du public dans les conditions prévues par la réglementation en vigueur et peut être consulté dans la rubrique «information réglementée» du site internet de la Société (). LVMH LVMH Moët Hennessy Louis Vuitton est présent dans les Vins & Spiritueux au travers notamment des Maisons Moët & Chandon, Dom Pérignon, Veuve Cli...
Progress on share buyback programme Progress on share buyback programme ING announced today that, as part of our €2.0 billion share buyback programme announced on 2 May 2025, in total 2,480,240 shares were repurchased during the week of 28 July 2025 up to and including 1 August 2025. The shares were repurchased at an average price of €20.35 for a total amount of €50,462,143.07. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at . In line with the purpose of the programme to reduce the share capital ...
EBA stress test confirms ING’s resilient capital position EBA stress test confirms ING’s resilient capital position Today, the European Banking Authority (EBA), in cooperation with the European Central Bank (ECB), the European Systemic Risk Board (ESRB) and De Nederlandsche Bank (DNB), published the results of the 2025 EU-wide stress test for European banks, including ING. ING notes the announcements made today by the EBA on the stress test and acknowledges the outcomes of this exercise. The 2025 EU-wide stress test does not contain a pass/fail threshold and instead is designed to be used...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.